[HTML][HTML] State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PET
T Carlier, C Bailly - Frontiers in medicine, 2015 - frontiersin.org
18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) is an important
tool in oncology. Its use has greatly progressed from initial diagnosis to staging and patient …
tool in oncology. Its use has greatly progressed from initial diagnosis to staging and patient …
FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity
B Saboury, A Salavati, A Brothers, S Basu… - European journal of …, 2014 - Springer
Purpose The aim of this study was to determine the feasibility and potential clinical utility of
assessment of Crohn's disease (CD) activity by 18 F-fluorodeoxyglucose (FDG) positron …
assessment of Crohn's disease (CD) activity by 18 F-fluorodeoxyglucose (FDG) positron …
[HTML][HTML] 18F-FDG and 11C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers
MI Morales-Lozano, O Viering, S Samnick… - Cancers, 2020 - mdpi.com
11C-methionine (11C-MET) is a new positron emission tomography (PET) tracer for the
assessment of disease activity in multiple myeloma (MM) patients, with preliminary data …
assessment of disease activity in multiple myeloma (MM) patients, with preliminary data …
[HTML][HTML] Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients
B Marinelli, C Espinet-Col, GA Ulaner… - American journal of …, 2016 - ncbi.nlm.nih.gov
Abstract FDG PET/CT-based measures of tumor burden show promise to predict survival in
patients with metastatic breast cancer, but the patient populations studied so far are …
patients with metastatic breast cancer, but the patient populations studied so far are …
Characterizing POEMS Syndrome with 18F-FDG PET/CT
Q Pan, J Li, F Li, D Zhou, Z Zhu - Journal of Nuclear Medicine, 2015 - Soc Nuclear Med
POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein elevation, and skin
changes) syndrome is a rare paraneoplastic syndrome caused by an underlying plasma cell …
changes) syndrome is a rare paraneoplastic syndrome caused by an underlying plasma cell …
[HTML][HTML] 11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value
MI Morales-Lozano, P Rodriguez-Otero… - International Journal of …, 2022 - mdpi.com
Multiple myeloma (MM) is the second most common haematological malignancy and
remains incurable despite therapeutic advances. 18F-FDG (FDG) PET/CT is a relevant tool …
remains incurable despite therapeutic advances. 18F-FDG (FDG) PET/CT is a relevant tool …
PET/CT studies of multiple myeloma using 18 F-FDG and 18 F-NaF: comparison of distribution patterns and tracers' pharmacokinetics
C Sachpekidis, H Goldschmidt, D Hose, L Pan… - European journal of …, 2014 - Springer
Objective The aim of this prospective study is to evaluate the combined use of fluorine-18
fluorodeoxyglucose (18 F-FDG) and fluorine-18 sodium fluoride (18 F-NaF) PET/CT in the …
fluorodeoxyglucose (18 F-FDG) and fluorine-18 sodium fluoride (18 F-NaF) PET/CT in the …
Increased bone marrow plasma-cell percentage predicts outcomes in newly diagnosed multiple myeloma patients
Background Previous reports have suggested that a higher bone marrow plasma-cell
percentage (BMPC%) is associated with worse outcomes. However, it is unknown whether …
percentage (BMPC%) is associated with worse outcomes. However, it is unknown whether …
Minimal residual disease and imaging‐guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma
D Böckle, P Tabares, X Zhou… - British Journal of …, 2022 - Wiley Online Library
Measurement of minimal residual disease (MRD) by next‐generation flow cytometry (NGF)
is an important tool to define deep responses in multiple myeloma (MM). However, little is …
is an important tool to define deep responses in multiple myeloma (MM). However, little is …
[PDF][PDF] Established and novel prognostic biomarkers in multiple myeloma
Multiple myeloma (MM) is an incurable plasma cell malignancy characterized by notable
interpatient heterogeneity. There have been important advances in therapy and overall …
interpatient heterogeneity. There have been important advances in therapy and overall …